Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Ximedica Names Randall Barko President & CEO

RELATED NEWS
Trade FLEX now with 
4/9/2012 12:37 PM ET

Ximedica announced that it has appointed Randall Barko to serve as its President & Chief Executive Officer. Barko succeeds Stephen Lane, Ximedica's founding Chief Executive Officer. Lane will assume the role of Chairman and Chief Venture Officer focusing on adjacent growth opportunities. The new appointments will take effect immediately.

Randy comes to Ximedica with over 30 years of leading medical device and healthcare organizations towards global and financial growth. He has served as an executive advisor to Ximedica for the past 3 years. Currently Barko serves on the Board of Directors of several privately owned companies and is involved with several private equity and venture capital groups.

Prior to these roles, Randy was Vice President of Corporate Development at Flextronics (FLEX: Quote) and was Corporate Vice President, Marketing & Business Development and member of the Board of Directors at Nypro Inc. Barko was also President & CEO of the Nypro Medical Products Group and Chairman of NP Medical Inc.

Click here to receive FREE breaking news email alerts for Flextronics International Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
China's manufacturing sector contracted for the first time in seven months in May amid poor demand, fueling concerns that the weakness in the economy may persist for some more time. The headline purchasing managers' index, an indicator of the health of the factory sector, fell to a seven-month low of 49.6 in May from 50.4 in April. Readings below 50 indicate contraction of the sector. Hewlett-Packard Co. said Wednesday after the markets closed that its second quarter profit fell 32% from last year, hurt by lower revenue and weaker margins amid a slump in PC sales. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast. Stocks showed a substantial downturn over the course of the trading day on Wednesday after seeing some strength in morning trading. Renewed worries about the Federal Reserve tapering its asset purchase program contributed to the sharp pullback by the markets. The major averages climbed off their worst levels going into the close but still ended the day firmly negative.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.